Most Popular
-
1
Heavy snow alerts issued in greater Seoul area, Gangwon Province; over 20 cm of snow seen in Seoul
-
2
Seoul blanketed by heaviest Nov. snow, with more expected
-
3
NewJeans to terminate contract with Ador
-
4
Seoul snowfall now third heaviest on record
-
5
Samsung shakes up management, commits to reviving chip business
-
6
Heavy snow of up to 40 cm blankets Seoul for 2nd day
-
7
How $70 funeral wreaths became symbol of protest in S. Korea
-
8
Hybe consolidates chairman Bang Si-hyuk’s regime with leadership changes
-
9
Why cynical, 'memeified' makeovers of kids' characters are so appealing
-
10
NewJeans terminates contract with Ador, embarks on new journey
Authorities suspended the trading of biotech HLB’s stocks on Wednesday to offset a sudden 40 percent jump over two days on the back of hyped expectations for a new cancer drug.
HLB will have a pre-new drug application meeting for Rivoceranib with the US’ Food and Drug Administration on Friday, by Korean time.
HLB stock ended Tuesday 7.75 percent higher at 180,800 won ($154) after hitting a new 52-week high of 209,700 won during intraday trading, edging out Celltrion Healthcare.
On the previous day, it had jumped 29.98 percent -- hitting the daily limit.
HLB is now the second most valuable stock on the secondary Kosdaq with a market capitalization of 7.09 trillion won.
HLB is short for Hyundai Life Boat. It was founded in 1975 as a lifeboat manufacturing company under Hyundai Group. It is the world’s second and Korea’s only lifeboat manufacturer, producing 700 boats a year.
The company underwent multiple mergers and acquisitions and expanded to biotech research and development in 2015.
By Lim Jeong-yeo (kaylalim@heraldcorp.com)
HLB will have a pre-new drug application meeting for Rivoceranib with the US’ Food and Drug Administration on Friday, by Korean time.
HLB stock ended Tuesday 7.75 percent higher at 180,800 won ($154) after hitting a new 52-week high of 209,700 won during intraday trading, edging out Celltrion Healthcare.
On the previous day, it had jumped 29.98 percent -- hitting the daily limit.
HLB is now the second most valuable stock on the secondary Kosdaq with a market capitalization of 7.09 trillion won.
HLB is short for Hyundai Life Boat. It was founded in 1975 as a lifeboat manufacturing company under Hyundai Group. It is the world’s second and Korea’s only lifeboat manufacturer, producing 700 boats a year.
The company underwent multiple mergers and acquisitions and expanded to biotech research and development in 2015.
By Lim Jeong-yeo (kaylalim@heraldcorp.com)
